These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 28129328

  • 1. Chlamydia trachomatis Pgp3 Antibody Population Seroprevalence before and during an Era of Widespread Opportunistic Chlamydia Screening in England (1994-2012).
    Woodhall SC, Wills GS, Horner PJ, Craig R, Mindell JS, Murphy G, McClure MO, Soldan K, Nardone A, Johnson AM.
    PLoS One; 2017; 12(1):e0152810. PubMed ID: 28129328
    [Abstract] [Full Text] [Related]

  • 2. C. trachomatis Pgp3 antibody prevalence in young women in England, 1993-2010.
    Horner P, Soldan K, Vieira SM, Wills GS, Woodhall SC, Pebody R, Nardone A, Stanford E, McClure MO.
    PLoS One; 2013; 8(8):e72001. PubMed ID: 23991024
    [Abstract] [Full Text] [Related]

  • 3. Assessment and utility of 2 Chlamydia trachomatis Pgp3 serological assays for seroprevalence studies among women in the United States.
    Danavall DC, Gwyn S, Anyalechi GE, Bowden KE, Hong J, Kirkcaldy RD, Bernstein KT, Kersh EN, Martin D, Raphael BH.
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115480. PubMed ID: 34325205
    [Abstract] [Full Text] [Related]

  • 4. Sera selected from national STI surveillance system shows Chlamydia trachomatis PgP3 antibody correlates with time since infection and number of previous infections.
    Blomquist PB, Mighelsen SJ, Wills G, McClure E, Ades AE, Kounali D, Dunbar JK, McClure MO, Soldan K, Woodhall SC, Horner P.
    PLoS One; 2018 Oct; 13(12):e0208652. PubMed ID: 30557408
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chlamydia trachomatis Incidence Using Self-Reports and Serology by Gender, Age Period, and Sexual Behavior in a Birth Cohort.
    Righarts AA, Morgan J, Horner PJ, Wills GS, McClure MO, Dickson NP.
    Sex Transm Dis; 2017 Jun; 44(6):344-350. PubMed ID: 28499283
    [Abstract] [Full Text] [Related]

  • 8. Chlamydia trachomatis IgG seroprevalence in the general population of the Netherlands in 1996 and in 2007: differential changes by gender and age.
    van Aar F, de Moraes M, Morré SA, van Bergen JE, van der Klis FR, Land JA, van der Sande MA, van den Broek IV.
    Sex Transm Infect; 2014 Aug; 90(5):434-40. PubMed ID: 24583966
    [Abstract] [Full Text] [Related]

  • 9. Development and evaluation of an enzyme-linked immunosorbent assay for the detection of antibodies to a common urogenital derivative of Chlamydia trachomatis plasmid-encoded PGP3.
    Winstanley CE, Ramsey KH, Marsh P, Clarke IN.
    J Immunol Methods; 2017 Jun; 445():23-30. PubMed ID: 28283408
    [Abstract] [Full Text] [Related]

  • 10. Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.
    Burr SE, Hart J, Samikwa L, Chaima D, Cooley G, Martin D, Masika M, Solomon AW, Bailey RL, Kalua K.
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007749. PubMed ID: 31658258
    [Abstract] [Full Text] [Related]

  • 11. Effect of time since exposure to Chlamydia trachomatis on chlamydia antibody detection in women: a cross-sectional study.
    Horner PJ, Wills GS, Reynolds R, Johnson AM, Muir DA, Winston A, Broadbent AJ, Parker D, McClure MO.
    Sex Transm Infect; 2013 Aug; 89(5):398-403. PubMed ID: 23430706
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and persistence of Chlamydia trachomatis-specific antibodies after occasional and recurrent infections.
    Öhman H, Rantsi T, Joki-Korpela P, Tiitinen A, Surcel HM.
    Sex Transm Infect; 2020 Jun; 96(4):277-282. PubMed ID: 31320394
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Seroprevalence of Chlamydia trachomatis in Inner-City Children and Adolescents-Implications for Vaccine Development.
    Banniettis N, Thumu S, Weedon J, Chotikanatis K, Szigeti A, Hammerschlag MR, Kohlhoff SA.
    Sex Transm Dis; 2017 Dec; 44(12):717-721. PubMed ID: 28876302
    [Abstract] [Full Text] [Related]

  • 16. Humoral immune response to plasmid protein pgp3 in patients with Chlamydia trachomatis infection.
    Comanducci M, Manetti R, Bini L, Santucci A, Pallini V, Cevenini R, Sueur JM, Orfila J, Ratti G.
    Infect Immun; 1994 Dec; 62(12):5491-7. PubMed ID: 7960130
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the reproducibility of a serological test for antibodies to Chlamydia trachomatis pgp3: A potential surveillance tool for trachoma programs.
    Kaur H, Dize L, Munoz B, Gaydos C, West SK.
    J Microbiol Methods; 2018 Apr; 147():56-58. PubMed ID: 29501689
    [Abstract] [Full Text] [Related]

  • 18. Seroprevalence of Chlamydia trachomatis in Enugu, Nigeria.
    Ikeme AC, Ezegwui HU, Ikeako LC, Agbata I, Agbata E.
    Niger J Clin Pract; 2011 Apr; 14(2):176-80. PubMed ID: 21860135
    [Abstract] [Full Text] [Related]

  • 19. Trends in Chlamydia trachomatis IgG seroprevalence in the general population of the Netherlands over 20 years.
    Alexiou ZW, van Aar F, Hoenderboom BM, Morre SA, Heijne JCM.
    Sex Transm Infect; 2024 Jan 17; 100(1):31-38. PubMed ID: 37985129
    [Abstract] [Full Text] [Related]

  • 20. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection.
    Fenton KA, Korovessis C, Johnson AM, McCadden A, McManus S, Wellings K, Mercer CH, Carder C, Copas AJ, Nanchahal K, Macdowall W, Ridgway G, Field J, Erens B.
    Lancet; 2001 Dec 01; 358(9296):1851-4. PubMed ID: 11741624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.